Description:

SOUTHWEST ONCOLOGY GROUP Post-Consolidation Eligibility Form: Maintenance Chemotherapy (S0521) NCT00492856 Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=02DB0EF4-F2F0-5AA4-E044-0003BA3F9857

Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=02DB0EF4-F2F0-5AA4-E044-0003BA3F9857
Keywords:
  1. 9/19/12 9/19/12 -
  2. 1/9/15 1/9/15 - Martin Dugas
  3. 6/9/15 6/9/15 -
Uploaded on:

June 9, 2015

DOI:
To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

SOUTHWEST ONCOLOGY GROUP Post-Consolidation Eligibility Form: Maintenance Chemotherapy (S0521) NCT00492856

No Instruction available.

  1. StudyEvent: SOUTHWEST ONCOLOGY GROUP Post-Consolidation Eligibility Form: Maintenance Chemotherapy (S0521)
    1. No Instruction available.
Header
Participating Group Name
Post-Consolidation Eligibility Assessment
Was an RT-PCR result obtained from the marrow specimen
Was an RT-PCR result obtained from the blood specimen
Performance Status
Comments

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial